| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8792236 | Journal of American Association for Pediatric Ophthalmology and Strabismus | 2018 | 6 Pages |
Abstract
In this patient cohort 2-year follow-up evaluation of infants treated with bevacizumab versus laser therapy for retinopathy of prematurity showed no adverse effects on medical or neurodevelopmental outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Kathleen A. MD, MPH, Helen A. MD, BEAT-ROP Cooperative Group BEAT-ROP Cooperative Group,